Allocade

About Allocade

Founded in 2007 by Michael Cline and Tom Spann, and headquartered in Plymouth Meeting, Pennsylvania, Allocade, Inc. operates as a key player in the personalized healthcare advocacy sector. The company's creation was reportedly inspired by co-founder Michael Cline's personal difficulties navigating the healthcare system, which highlighted a need for enhanced patient guidance. Allocade's primary business model is centered on a B2B approach, serving employers who then offer the company's healthcare solutions to their employees and families. As of early 2024, the company catered to over 1,200 commercial customers, reaching more than 14 million members.

Allocade's revenue is primarily generated through recurring per-member-per-month (PMPM) fees paid by employers and health plans. This subscription-based model is often supplemented by performance-based contracts, which are tied to documented healthcare cost reductions for their clients. The company's service offerings are diverse, encompassing personalized health guidance, expert medical opinion services, and virtual primary care. This is delivered through a combination of human interaction and technology; each member is paired with a Care Advocate who provides support, while an underlying technology platform utilizes AI and data analytics to offer personalized recommendations and streamline the healthcare experience. This integrated platform aims to address the complexities of the healthcare system, helping members understand benefits, find providers, and make informed care decisions.

The company has expanded its capabilities through strategic acquisitions. In 2021 and 2022, Allocade acquired PlushCare, 2nd.MD, and HealthReveal, which allowed it to integrate virtual primary care, mental health support, and expert medical opinion services into its platform. This evolution transformed the company from a navigation service to a more comprehensive healthcare provider. The company went public on the Nasdaq stock exchange under the ticker symbol ACCD in 2020. In early 2025, it was announced that Allocade was acquired by Transcarent.